A family of drug transporters: the multidrug resistance-associated proteins.
暂无分享,去创建一个
M. Kool | R. Evers | J. Wijnholds | P. Borst | P Borst | R Evers | M Kool | J Wijnholds | Marcel Kool
[1] F. Baas,et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] M. Kool,et al. Mutations in ABCC6 cause pseudoxanthoma elasticum , 2000, Nature Genetics.
[3] S. Terry,et al. Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum , 2000, Nature Genetics.
[4] M. Lebwohl,et al. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[5] D D Breimer,et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. , 2000, The Journal of clinical investigation.
[6] G. Peters,et al. Advances in Brief Antifolate Resistance Mediated by the Multidrug Resistance Proteins MRP 1 and MRP 21 , 2000 .
[7] D. Keppler,et al. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. , 1999, Biochimica et biophysica acta.
[8] D. Hipfner,et al. Structural, mechanistic and clinical aspects of MRP1. , 1999, Biochimica et biophysica acta.
[9] M. Kool,et al. The multidrug resistance protein family. , 1999, Biochimica et biophysica acta.
[10] J. Schuetz,et al. MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugs , 1999, Nature Medicine.
[11] J. Wijnholds,et al. The mouse Bcrp1/Mxr/Abcp gene: amplification and overexpression in cell lines selected for resistance to topotecan, mitoxantrone, or doxorubicin. , 1999, Cancer research.
[12] A. Sartorelli,et al. New insights into the biology and pharmacology of the multidrug resistance protein (MRP) from gene knockout models. , 1999, Biochemical pharmacology.
[13] M. Breen,et al. pABC11 (Also Known as MOAT-C and MRP5), a Member of the ABC Family of Proteins, Has Anion Transporter Activity but Does Not Confer Multidrug Resistance When Overexpressed in Human Embryonic Kidney 293 Cells* , 1999, The Journal of Biological Chemistry.
[14] Y. Sugiyama,et al. Transepithelial transport of organic anions across the choroid plexus: possible involvement of organic anion transporter and multidrug resistance-associated protein. , 1999, The Journal of pharmacology and experimental therapeutics.
[15] G. Kruh,et al. © 1999 Cancer Research Campaign Article no. bjoc.1999.0527 MOAT-E (ARA) is a full-length MRP/cMOAT subfamily , 2022 .
[16] G. Peters,et al. MRP3, an organic anion transporter able to transport anti-cancer drugs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[17] P. Novikoff,et al. MRP3, a new ATP-binding cassette protein localized to the canalicular domain of the hepatocyte. , 1999, The American journal of physiology.
[18] Hiroshi Suzuki,et al. Characterization of the Transport Properties of Cloned Rat Multidrug Resistance-associated Protein 3 (MRP3)* , 1999, The Journal of Biological Chemistry.
[19] D. Keppler,et al. Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells. , 1999, Molecular pharmacology.
[20] D. Keppler,et al. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane , 1999, Hepatology.
[21] A. Sartorelli,et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Voskoglou-Nomikos,et al. Expression of multidrug resistance protein-related genes in lung cancer: correlation with drug response. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] D. Keppler,et al. Selective inhibition of MDR1 P-glycoprotein-mediated transport by the acridone carboxamide derivative GG918 , 1999, British Journal of Cancer.
[24] P. Jansen,et al. ATP‐ and glutathione‐dependent transport of chemotherapeutic drugs by the multidrug resistance protein MRP1 , 1999, British journal of pharmacology.
[25] S. Waxman,et al. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. , 1999, Blood.
[26] Ronald,et al. MRP 3 , an organic anion transporter able to transport anti-cancer drugs ( multidrug resistance y methotrexate y etoposide ) , 1999 .
[27] M. Kool,et al. Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells. , 1999, Cancer research.
[28] S. Cole. Re: Characterization of MOAT-C and MOAT-D, new members of the MRP/cMOAT subfamily of transporter proteins. , 1999, Journal of the National Cancer Institute.
[29] T. Litman,et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes. , 1999, Cancer research.
[30] Yong-kui,et al. Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. , 1999, Journal of the National Cancer Institute.
[31] L. Doyle,et al. A multidrug resistance transporter from human MCF-7 breast cancer cells. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] Vincenzo,et al. A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance. , 1998, Cancer research.
[33] G. Szakács,et al. Functional Multidrug Resistance Protein (MRP1) Lacking the N-terminal Transmembrane Domain* , 1998, The Journal of Biological Chemistry.
[34] S. Cole,et al. Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione. , 1998, Cancer research.
[35] J. Wijnholds,et al. Multidrug Resistance Protein 1 Protects the Oropharyngeal Mucosal Layer and the Testicular Tubules against Drug-induced Damage , 1998, The Journal of experimental medicine.
[36] N. Doggett,et al. ARA, a novel ABC transporter, is located at 16p13.1, is deleted in inv(16) leukemias, and is shown to be expressed in primitive hematopoietic precursors. , 1998, Genomics.
[37] G R Lankas,et al. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. , 1998, Reproductive toxicology.
[38] Y. Sugiyama,et al. Hepatic expression of multidrug resistance-associated protein-like proteins maintained in eisai hyperbilirubinemic rats. , 1998, Molecular pharmacology.
[39] G. Peters,et al. Amplification and expression of the ABC transporters ARA and MRP in a series of multidrug-resistant leukaemia cell sublines. , 1998, British Journal of Cancer.
[40] S. Cole,et al. Multidrug Resistance Protein , 1998, The Journal of Biological Chemistry.
[41] D. Keppler,et al. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance protein MRP1 and its apical isoform MRP2. , 1998, Chemico-biological interactions.
[42] P. Meier,et al. The Sister of P-glycoprotein Represents the Canalicular Bile Salt Export Pump of Mammalian Liver* , 1998, The Journal of Biological Chemistry.
[43] M. Kool,et al. Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA. , 1998, The Journal of clinical investigation.
[44] T. Ishikawa,et al. Frequent coexpression of MRP/GS-X pump and gamma-glutamylcysteine synthetase mRNA in drug-resistant cells, untreated tumor cells, and normal mouse tissues. , 1998, Biochemical pharmacology.
[45] T. Fojo,et al. Future perspectives for the development of P-glycoprotein modulators. , 1998, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[46] M. Kool,et al. Expression of Human MRP 6 , a Homologue of the Multidrug Resistance Protein Gene MRP 1 , in Tissues and Cancer Cells 1 , 1998 .
[47] T. Uchiumi,et al. A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells. , 1997, Cancer research.
[48] R. Flavell,et al. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. , 1997, Cancer research.
[49] R. Flavell,et al. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. , 1997, Cancer research.
[50] G. Eytan,et al. Flip-flop of doxorubicin across erythrocyte and lipid membranes. , 1997, Biochemical pharmacology.
[51] Jos H. Beijnen,et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein , 1997, Nature Medicine.
[52] B. Sikic. Pharmacologic approaches to reversing multidrug resistance. , 1997, Seminars in hematology.
[53] Y. Sugiyama,et al. Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. , 1997, Cancer research.
[54] M. Kool,et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. , 1997, Cancer research.
[55] M. Müller,et al. Regulation of organic anion transport in the liver. , 1997, The Yale journal of biology and medicine.
[56] P. Borst. Introduction: multidrug resistant proteins , 1997 .
[57] K. Linton,et al. Structure of the multidrug resistance P-glycoprotein. , 1997, Seminars in cancer biology.
[58] M. Kool,et al. A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin‐Johnson syndrome , 1997, Hepatology.
[59] P. Borst,et al. Genetic dissection of the function of mammalian P-glycoproteins. , 1997, Trends in genetics : TIG.
[60] C. Higgins,et al. Structure of the Multidrug Resistance P-glycoprotein to 2.5 nm Resolution Determined by Electron Microscopy and Image Analysis* , 1997, The Journal of Biological Chemistry.
[61] P. Borst,et al. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[62] J. Beijnen,et al. Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[63] J. Schifferli,et al. Paraproteins and complement depletion: pathogenesis and clinical syndromes. , 1997, Seminars in hematology.
[64] P. Borst. Multidrug resistant proteins. , 1997, Seminars in cancer biology.
[65] R. Flavell,et al. Double knockout of the MRP gene leads to increased drug sensitivity in vitro. , 1996, Cancer research.
[66] M. Saxena,et al. MOAT4, a novel multispecific organic-anion transporter for glucuronides and mercapturates in mouse L1210 cells and human erythrocytes. , 1996, The Biochemical journal.
[67] S. Cole,et al. Reconstitution of ATP-dependent Leukotriene C4 Transport by Co-expression of Both Half-molecules of Human Multidrug Resistance Protein in Insect Cells* , 1996, The Journal of Biological Chemistry.
[68] R. Davey,et al. The anthracycline resistance-associated (ara) gene, a novel gene associated with multidrug resistance in a human leukaemia cell line. , 1996, British Journal of Cancer.
[69] A. Hutchinson,et al. Characterization of the human ABC superfamily: isolation and mapping of 21 new genes using the expressed sequence tags database. , 1996, Human molecular genetics.
[70] M. Tanimoto,et al. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. , 1996, Cancer research.
[71] T. Ishikawa,et al. Coordinated Induction of MRP/GS-X Pump and γ-Glutamylcysteine Synthetase by Heavy Metals in Human Leukemia Cells* , 1996, The Journal of Biological Chemistry.
[72] D. Keppler,et al. cDNA Cloning of the Hepatocyte Canalicular Isoform of the Multidrug Resistance Protein, cMrp, Reveals a Novel Conjugate Export Pump Deficient in Hyperbilirubinemic Mutant Rats* , 1996, The Journal of Biological Chemistry.
[73] U. Germann,et al. P-glycoprotein--a mediator of multidrug resistance in tumour cells. , 1996, European journal of cancer.
[74] D. Keppler,et al. Absence of the canalicular isoform of the MRP gene–encoded conjugate export pump from the hepatocytes in Dubin‐Johnson syndrome , 1996, Hepatology.
[75] S. Cole,et al. Multidrug Resistance Protein (MRP)-mediated Transport of Leukotriene C and Chemotherapeutic Agents in Membrane Vesicles , 1996, The Journal of Biological Chemistry.
[76] S. Cole,et al. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. , 1996, The Journal of biological chemistry.
[77] B. Sarkadi,et al. Transport properties of the multidrug resistance‐associated protein (MRP) in human tumour cells , 1996, FEBS letters.
[78] D. Keppler,et al. Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. , 1996, Cancer research.
[79] R. Evers,et al. Basolateral localization and export activity of the human multidrug resistance-associated protein in polarized pig kidney cells. , 1996, The Journal of clinical investigation.
[80] P. Bosma,et al. Congenital Jaundice in Rats with a Mutation in a Multidrug Resistance-Associated Protein Gene , 1996, Science.
[81] W. Hait,et al. P-glycoprotein-mediated multidrug resistance: experimental and clinical strategies for its reversal. , 1996, Cancer treatment and research.
[82] F. Baas,et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[83] D. Meijer,et al. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. , 1995, Biochimica et biophysica acta.
[84] R. Scheper,et al. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. , 1995, British Journal of Cancer.
[85] P. Borst,et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[86] Christine,et al. GS-X pump is functionally overexpressed in cis-diamminedichloroplatinum (II)-resistant human leukemia HL-60 cells and down-regulated by cell differentiation. , 1994, The Journal of biological chemistry.
[87] G. M. Wilson,et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.
[88] D. Keppler,et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. , 1994, The Journal of biological chemistry.
[89] D. Keppler,et al. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. , 1994, Cancer research.
[90] J. H. Beijnen,et al. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs , 1994, Cell.
[91] T. Hughes,et al. Functional implications from the effects of 1-chloro-2,4-dinitrobenzene and ethacrynic acid on efflux routes for methotrexate and cholate in L1210 cells. , 1994, The Journal of biological chemistry.
[92] D. Hipfner,et al. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. , 1994, Cancer research.
[93] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[94] T. Ishikawa,et al. The ATP-dependent glutathione S-conjugate export pump. , 1992, Trends in biochemical sciences.
[95] S. Cole,et al. P-glycoprotein-mediated multidrug resistance and cytotoxic effector cells. , 1992, Natural immunity.
[96] T. van der Velde-Koerts,et al. Structure of the human MDR3 gene and physical mapping of the human MDR locus. , 1991, The Journal of biological chemistry.
[97] T. Ishikawa. [ATP-dependent transport of leukotriene C4]. , 1990, Seikagaku. The Journal of Japanese Biochemical Society.
[98] V. Ling,et al. Multidrug resistance in cancer. , 1989, Scientific American.
[99] R L Juliano,et al. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. , 1976, Biochimica et biophysica acta.
[100] K. Danø. Active outward transport of daunomycin in resistant Ehrlich ascites tumor cells. , 1973, Biochimica et biophysica acta.